Cao Jibin, Xu Xiaohan, Zhu Jingyi, Wu Puyeh, Pang Huize, Fan Guoguang, Cui Lingling
Department of Radiology, The First Hospital of China Medical University, Shenyang, China.
GE Healthcare, Beijing, China.
Quant Imaging Med Surg. 2022 Jun;12(6):3104-3114. doi: 10.21037/qims-21-970.
Early pathologic studies have reported that focal areas of gray lesions in the cortex and other gray matter (GM) regions are important in multiple sclerosis (MS) patients. Quantitative magnetic resonance imaging (qMRI) can provide more specific insight into the disease process, progression, and therapeutic response of MS. The purpose of this study was to quantitatively assess the changes of global GM volumetry and relaxometry information simultaneously in MS patients using synthetic MRI.
All MS patients and healthy controls (HCs) were recruited. The Expanded Disability Status Scale (EDSS) scores were obtained from all patients to evaluate the disability progression. Volumetry and relaxometry of the global brain and regional GM were obtained. The quantitative parameters between MS patients and HCs were compared using an analysis of covariance (ANCOVA). The Pearson correlation assessed the correlations between the quantitative parameters and EDSS, illness duration, education in MS patients.
Thirty-five MS patients and fifty-two age-matched HCs were enrolled in this prospective case-control study. The global volumetry including white matter volume (WMV), myelin volume (MYV), and brain parenchymal volume (BPV) were all significantly lower in MS patients (WMV: 613.120±65.388 579.903±68.432 mL; MYV: 151.883±22.766 192.457±27.381 mL; BPV: 1,136.771±106.126 1,276.712±107.368 mL), as well as a higher cerebral spinal fluid volume (CSFV) (241.294±81.805 177.017±39.729 mL) in MS patients than those in HCs. Similarly, brain parenchymal fraction (BPF) and myelin fraction (MYF) were significantly lower in MS patients (BPF: 82.623±5.368 87.85±2.392 mL; MYF: 11.034±1.529 13.231±1.465 mL). For regional GM volumetry, multiple regions of MS patients were significantly smaller than those of HCs (P<0.01, corrected). For regional GM relaxometry, the T1, T2, and PD values of multiple regions showed significant differences.
These findings suggest that MS patients had global and regional brain volumetry and relaxometry alterations, and the synthetic MRI-derived parameters may be potentially used as specific quantitative markers for the clinic to improve the understanding of MS.
早期病理学研究报告称,皮质和其他灰质(GM)区域的局灶性灰色病变区域在多发性硬化症(MS)患者中具有重要意义。定量磁共振成像(qMRI)可以为MS的疾病过程、进展和治疗反应提供更具体的见解。本研究的目的是使用合成MRI定量评估MS患者整体GM体积测量和弛豫测量信息的变化。
招募所有MS患者和健康对照(HCs)。从所有患者处获取扩展残疾状态量表(EDSS)评分以评估残疾进展。获取全脑和区域GM的体积测量和弛豫测量数据。使用协方差分析(ANCOVA)比较MS患者和HCs之间的定量参数。Pearson相关性分析评估MS患者中定量参数与EDSS、病程、教育程度之间的相关性。
35例MS患者和52例年龄匹配的HCs纳入了这项前瞻性病例对照研究。MS患者的整体体积测量包括白质体积(WMV)、髓磷脂体积(MYV)和脑实质体积(BPV)均显著降低(WMV:613.120±65.388对579.903±68.432 mL;MYV:151.883±22.766对192.457±27.381 mL;BPV:1,136.771±106.126对1,276.712±107.368 mL),并且MS患者的脑脊液体积(CSFV)更高(241.294±81.805对177.017±39.729 mL)。同样,MS患者的脑实质分数(BPF)和髓磷脂分数(MYF)显著更低(BPF:82.623±5.368对87.85±2.392 mL;MYF:11.034±1.529对13.231±1.465 mL)。对于区域GM体积测量,MS患者的多个区域显著小于HCs(P<0.01,校正后)。对于区域GM弛豫测量,多个区域的T1、T2和PD值显示出显著差异。
这些发现表明MS患者存在整体和区域脑体积测量和弛豫测量改变,并且合成MRI衍生参数可能潜在地用作临床特异性定量标志物,以增进对MS的理解。